MARKET RESEARCH TREND

Description- Notes: Production, means the output of Human Insulin Revenue, means the sales value of Human Insulin This report studies Human Insulin in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Nono Nordisk Eli Llly Sanofi To Free Sample Report With TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=777763 Merk Tonghua Dongbao Gan Lee United Laboratories Jiangsu Wanbang Biopharmaceuticals ... By types, the market can be split into Regular Human Human Insulin Human Insulin Analogue Type III By Application, the market can be split into Short acting Intermediate acting Long acting Pre-mix Human Insulin

Description - Human Insulin : Asia Pacific Diabetes refers to a group of metabolic disease characterized by high blood sugar level. It occurs due to inadequate secretion of insulin inside the pancreas. Some of the common symptoms for diabetes are frequent urination, excessive thirst, increased hunger, weight loss and tiredness. Type 1, type 2 and gestational diabetes are three common types of diabetes. Type 1 diabetes is an autoimmune disease occurred due to high blood glucose level whereas, type 2 diabetes is a lifelong chronic disease caused due to excess secretion of insulin inside the body. Type 2 diabetes is the common form of diabetes. Diabetes is more common in aged people; however, its prevalence is steadily increasing in adults and children. Severe problems such as blindness, kidney failure, coronary heart disease and strokes may result due to lack of proper treatment of diabetes. It also causes blindness, amputation, and kidney failure. Diabetes can be treated by main